Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced NSCLC × 1 year × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 660 Carcinoma, Non-Small-Cell Lung 458 Prostatic Neoplasms 389 Neoplasms 364 Lung Neoplasms 253 Multiple Myeloma 246 Colorectal Neoplasms 227 Neoplasm Metastasis 219 Melanoma 201 Ovarian Neoplasms 170 Leukemia, Myeloid, Acute 168 Pancreatic Neoplasms 157 Squamous Cell Carcinoma of Head and Neck 141 Carcinoma, Renal Cell 137 Brain Neoplasms 137 Lymphoma 136 Glioblastoma 128 Lymphoma, Non-Hodgkin 125 Recurrence 124 Leukemia, Lymphocytic, Chronic, B-Cell 123 Carcinoma, Hepatocellular 117 Head and Neck Neoplasms 111 Triple Negative Breast Neoplasms 108 Stomach Neoplasms 105 Urinary Bladder Neoplasms 103 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Hematologic Neoplasms 100 Lymphoma, Large B-Cell, Diffuse 95 Sarcoma 93 Uterine Cervical Neoplasms 90

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡